Home › Funds › Distillate Capital Partners LLC › THC
Distillate Capital Partners LLC position in THC
TENET HEALTHCARE CORP · Health Care
Distillate Capital Partners LLC reported holding 78,178 shares of THC (TENET HEALTHCARE CORP) in its Q3 2026 13F filing — a position valued at US$20.0M, representing 0.95% of its reported portfolio and ranking #40 among its reported holdings. Distillate Capital Partners LLC has disclosed THC holdings in 3 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Distillate Capital Partners LLC's THC position evolved
Distillate Capital Partners LLC first disclosed a stake in THC in Q4 2025 at 88,915 shares (US$17.7M). The position peaked in Q3 2026 at 78,178 shares, worth US$20.0M. Across 3 filings, Distillate Capital Partners LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 78,178 shares valued at US$20.0M — a reduction of -14,292 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 88.92K | $17.67M | New |
| Q2 2026 | 92.47K | $17.30M | New |
| Q3 2026 | 78.18K | $19.98M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 35 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$1.04B), GLENVIEW CAPITAL MANAGEMENT, LLC (US$523.3M), MANNING & NAPIER ADVISORS LLC (US$153.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.06M sh · $1.04B · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 2.05M sh · $523.35M · Q3 2026
- MANNING & NAPIER ADVISORS LLC 562.72K sh · $153.76M · Q3 2026
- EMINENCE CAPITAL, LP 790.30K sh · $149.14M · Q1 2026
More on Distillate Capital Partners LLC
FAQ
How long has Distillate Capital Partners LLC held THC?
Distillate Capital Partners LLC has disclosed THC holdings in 3 of the last 4 reported quarters, going back to Q4 2025.
What is Distillate Capital Partners LLC's current position in THC?
As of Q3 2026, Distillate Capital Partners LLC holds 78.18K shares of THC (TENET HEALTHCARE CORP), valued at $19.98M, representing 0.95% of its reported portfolio and ranking #40.
Has Distillate Capital Partners LLC been buying or selling THC?
In the latest 13F filing (Q3 2026), Distillate Capital Partners LLC reduced its position in THC. The position peaked in Q3 2026 at 78.18K shares.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.